Kristine Aquino, mentioned 23 times across podcast episodes and expert conversations analyzed by Sonic.

Kristine Aquino

Financial market analyst and commentator for Bloomberg.

Claims

As speaker

Mentioned in

Key positions and views

Inclusion in major indices like the Nasdaq 100 provides a 'natural boost' to a stock due to automatic buying from passive funds.

Large IPOs, such as SpaceX's, can create short-term market disruptions as investment funds sell other assets to raise the necessary capital.

The stock market is undergoing a 'rotation trade,' with capital moving from large technology companies into defensive, financial, and healthcare sectors.

Strategic partnerships, like the Hims & Hers deal with Novo Nordisk for Wegovy, are significant catalysts that drive positive analyst ratings and market attention.

Growth in the AI sector is a key driver for legacy tech companies, with firms like Cisco Systems expected to see a multi-billion dollar increase in their AI-related order outlook.

Timeline

Pre-IPO Period

On 'Balance of Power', Aquino discusses the upcoming SpaceX IPO as a short-term market concern, noting that some funds may need to sell existing holdings to raise cash for the offering.

First Week of Trading

Following the IPO, Aquino reports on 'Balance of Power' that SpaceX stock is on track to end its first week of trading approximately 35% higher than its IPO price.

June 18, 2026

On the 'Balance of Power' episode dated 6/18/2026, Aquino predicts SpaceX shares will receive a 'natural boost' after 15 days of trading due to its inclusion in the Nasdaq 100 index, which triggers buying from passive funds.

Recent Period

In a series of appearances on 'Bloomberg Daybreak' (US, Asia, Europe editions), Aquino's focus shifts to reporting on specific company news and analyst actions, repeatedly covering Hims & Hers Health, Applied Materials, and Cisco Systems.

Podcast consensus on Aquino

Points of consensus

▶Across multiple 'Bloomberg Daybreak' editions (US, Europe, Asia), Aquino consistently reports the same analyst ratings and price targets for Hims & Hers Health, Applied Materials, and Cisco Systems, indicating a unified and repeated message.May 2026

▶Aquino repeatedly identifies the partnership between Hims & Hers Health and Novo Nordisk as the primary catalyst for J.P. Morgan's 'overweight' rating on the company, citing it in claims and direct quotes.May 2026

▶She consistently predicts that SpaceX's inclusion in the Nasdaq 100 index will provide a 'natural boost' to its stock price due to automatic buying from passive investment funds, a point made in separate 'Balance of Power' episodes.Jun 2026

▶The options market pricing in a potential 13% share price move for Hims & Hers Health post-earnings is a specific data point Aquino highlights across all three 'Bloomberg Daybreak' editions.May 2026

Points of debate

▶The provided claims are all from Kristine Aquino herself and do not contain any disagreements or contrasting perspectives from other sources.

▶There are no instances where Aquino contradicts her own previous statements; her analysis on topics like the SpaceX IPO is consistent across different episodes.Jun 2026

▶While she discusses both a short-term market concern (funds selling assets for the SpaceX IPO) and a positive catalyst (SpaceX's Nasdaq inclusion), these are presented as two different phases of an event, not a point of debate.Jun 2026

▶The analyst ratings and market data she presents are reported as factual events without any alternative interpretations or dissenting views being offered.

Key themes

▶Market Mechanics and Structural ForcesJun 2026

Aquino frequently explains how structural market factors, rather than just company fundamentals, influence stock prices. This includes the impact of a large IPO on broader market liquidity and the automatic buying pressure created by a stock's inclusion in a major index like the Nasdaq 100.

Investors should look beyond company news to understand how index rebalancing and capital flows can create predictable, short-term price movements.

▶Company-Specific CatalystsMay 2026

She focuses on specific events that trigger significant analyst re-ratings and price target adjustments. Examples include Hims & Hers Health's partnership with Novo Nordisk and the growing AI order book for Cisco Systems.

Aquino's analysis suggests that strategic partnerships and exposure to high-growth sectors like AI and weight-loss drugs are key drivers of positive market sentiment and valuation changes.

▶Conveying Analyst SentimentMay 2026

A significant portion of her commentary involves relaying and contextualizing the actions of investment banks like JP Morgan, UBS, and Seaport Global. She details their initiations of coverage, rating changes, and price target increases for specific stocks.

Her role often serves as a conduit for institutional research, highlighting to a broader audience which companies are gaining or losing favor among influential Wall Street analysts.

▶Broader Market RotationsJun 2026

Beyond individual stocks, Aquino identifies macro-level shifts in investor capital. She specifically notes a 'rotation trade' occurring, with money flowing out of large tech companies and into more traditional sectors like defensives, financials, and healthcare.

This highlights the importance of sector-level analysis, as even strong companies in an out-of-favor sector can underperform while capital flows boost other areas of the market.

Source episodes

Suggested prompts

How does Kristine Aquino weigh the impact of structural market forces, like index inclusion, against company-specific fundamentals in her analysis? &nearr;What patterns can be identified in the types of company catalysts, such as partnerships or sector growth, that Aquino chooses to highlight? &nearr;Does Aquino's commentary primarily reflect existing institutional sentiment by reporting on analyst ratings, or does she offer her own independent analysis? &nearr;How has Aquino's thematic focus evolved from broader market events like the SpaceX IPO to the more granular, company-specific news covered in her 'Daybreak' appearances? &nearr;

Key concepts

Hims & Hers Health 3 ep Applied Materials 3 ep Cisco Systems 3 ep SpaceX IPO 3 ep Analyst Ratings & Price Targets 3 ep Options Markets 3 ep Nasdaq 100 Inclusion 2 ep Market Rotation 1 ep

Notable quotes

“And specifically for Cisco, that could result in an increase to about five billion dollars in its AI order outlook.”

Christine Aquino · Daybreak Weekend: US CPI, Cannes Festival, Bessent Visits Japan | Bloomberg Daybreak: US Edition

“Hims & Hers Health has formed a partnership with Novo Nordisk to sell the weight-loss drug WeGovi on its platform, resolving a previous dispute.”

Christine Aquino · Daybreak Weekend: US CPI, Cannes Festival, Bessent Visits Japan | Bloomberg Daybreak: US Edition

“Options markets are pricing a potential 13% move in the share price of Hims & Hers Health following its upcoming earnings report.”

Christine Aquino · Daybreak Weekend: US CPI, Cannes Festival, Bessent Visits Japan | Bloomberg Daybreak: Asia Edition

Report last updated: Jul 28, 2026

Create a free account to see Kristine Aquino's full intelligence report - every claim, the relationship network, and AI Q&A across all sources. No card needed.

Get started free

Back to Entities Intelligence Report